Trial intelligence / Profile preview

Lamotrigine Adjunctive Therapy in PGTC Seizures

NCT00043901Phase 4Completed

Sponsor
GSK
Start
Dec 2000
Primary completion
Nov 2003
Modality
Small Molecules
Countries
4
01

Overview

A Phase 4 trial of lamotrigine, sponsored by GSK. Started Dec 2000; status: completed.

02

Drugs

lamotrigine

Beyond the preview

Go deeper on NCT00043901.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00043901.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call